38.62
BATS BZX Real-Time Price
As of 12:10pm ET
 -0.25 / -0.64%
Today’s Change
29.39
Today|||52-Week Range
47.82
-8.72%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Generic
MARKET CAP
$19.7B

Company Description

Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe, Rest of World, and Corporate or Other. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The Corporate or Other segment covers other expenses not directly attributable to the segments and certain intercompany transactions of the firm. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom.

Contact Information

Mylan NV
Building 4
Hatfield Hertfordshire EN6 1AG
P:441707853000
Investor Relations:

Employees

Shareholders

Individual stakeholders5.71%
Mutual fund holders44.36%
Other institutional43.05%

Top Executives

Heather M. BreschChief Executive Officer & Executive Director
Rajiv MalikPresident & Executive Director
Haribabu BodepudiChief Operating Officer
Kenneth Scott ParksChief Financial Officer
Jonathan R. CollinsVice President & Head-eCommerce